國盛金控(002670.SZ):2022年度預虧4.35億元-6.15億元
格隆匯1月13日丨國盛金控(002670.SZ)披露2022年度業績預吿,預計2022年度實現歸屬於上市公司股東的淨利潤為虧損4.35億元-6.15億元,上年同期為盈利7688.86萬元;扣除非經常性損益後的淨利潤為虧損4.35億元-6.15億元,上年同期為盈利8125.77萬元。
2022年,受二級市場波動衝擊,證券市場景氣度下行,報吿期內公司業績出現虧損。主要原因系營收佔比較高的自營、經紀業務淨收入大幅減少;弱市背景下,期內公司投資收益同比大幅下降;由於市場情況變化,報吿期內,公司計提資產減值準備同比增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.